Crescent Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CBIO and other ETFs, options, and stocks.About CBIO
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
CEOJoshua T. Brumm
CEOJoshua T. Brumm
Employees26
Employees26
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2024
Founded2024
Employees26
Employees26
CBIO Key Statistics
Market cap146.84M
Market cap146.84M
Price-Earnings ratio-0.50
Price-Earnings ratio-0.50
Dividend yield—
Dividend yield—
Average volume76.19K
Average volume76.19K
High today$10.76
High today$10.76
Low today$10.57
Low today$10.57
Open price$10.76
Open price$10.76
Volume721.00
Volume721.00
52 Week high$37.00
52 Week high$37.00
52 Week low$9.81
52 Week low$9.81
Stock Snapshot
With a market cap of 146.84M, Crescent Biopharma(CBIO) trades at $10.57. The stock has a price-to-earnings ratio of -0.50.
During the trading session on 2026-01-08, Crescent Biopharma(CBIO) shares reached a daily high of $10.76 and a low of $10.57. At a current price of $10.57, the stock is 0.0% higher than the low and still -1.8% under the high.
Trading volume for Crescent Biopharma(CBIO) stock has reached 721, versus its average volume of 76.19K.
Over the past 52 weeks, Crescent Biopharma(CBIO) stock has traded between a high of $37.00 and a low of $9.81.
Over the past 52 weeks, Crescent Biopharma(CBIO) stock has traded between a high of $37.00 and a low of $9.81.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CBIO. This list is generated using Robinhood data, and it’s not a recommendation.